Cargando…

Gustave Roussy Immune Score as a Novel Prognostic Scoring System for Colorectal Cancer Patients: A Propensity Score Matching Analysis

AIM: The Gustave Roussy Immune Score (GRIm-Score) was originally designed to select cancer patients for immunotherapy, and later was reported to be a novel prognostic scoring system in lung cancer and esophageal cancer. This study was aimed to determine the prognostic role and predictive performance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Shan, Cao, Yinghao, Duan, Yanran, Liu, Qi, Peng, Pailan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669102/ https://www.ncbi.nlm.nih.gov/pubmed/34917499 http://dx.doi.org/10.3389/fonc.2021.737283

Ejemplares similares

Prognostic significance of the Gustave Roussy immune (GRIm) score in cancer patients: a meta-analysis
por: Sun, Ke-Xin, et al.
Publicado: (2023)

Prognostic value of modified-Gustave-Roussy Immunity Score in resectable proximal gastric cancer
por: Shi, Yujing, et al.
Publicado: (2023)

Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2020)

Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Prognostic Markers for Extensive Disease of Small Cell Lung Cancer
por: Minami, Seigo, et al.
Publicado: (2020)

Gustave Roussy immune score is a prognostic marker in patients with small cell lung cancer undergoing immunotherapy: a real-world retrospective study
por: Shangguan, Jian, et al.
Publicado: (2023)

Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Biomarkers of Immune-Checkpoint Inhibitor for Non-Small Cell Lung Cancer
por: Minami, Seigo, et al.
Publicado: (2019)

Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score
por: Li, Yongjiang, et al.
Publicado: (2022)

The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC‐GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis
por: Hatanaka, Takeshi, et al.
Publicado: (2022)

Gustave Roussy Immune Score Is a Prognostic Factor for Chemotherapy-Naive Pulmonary Adenocarcinoma With Wild-Type Epidermal Growth Factor Receptor
por: Minami, Seigo, et al.
Publicado: (2019)

Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy
por: Recondo, Gonzalo, et al.
Publicado: (2020)

Bilateral germ-cell tumours: 22-year experience at the Institut Gustave Roussy
por: Theodore, Ch, et al.
Publicado: (2004)

The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab
por: Lenci, Edoardo, et al.
Publicado: (2021)

Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Breast Cancer: A Propensity Score-Matching Study
por: Hua, Xin, et al.
Publicado: (2020)

Prognostic Effect of Age in Resected Pancreatic Cancer Patients: A Propensity Score Matching Analysis
por: Xu, Yaolin, et al.
Publicado: (2022)

Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis
por: Shin, Jung Kyong, et al.
Publicado: (2022)

Incidence of venous thromboembolism after surgery for adenocarcinoma in situ and the validity of the modified Caprini score: A propensity score-matched study
por: Cai, Yong-sheng, et al.
Publicado: (2022)

Effect of short-term prehabilitation of older patients with colorectal cancer: A propensity score-matched analysis
por: Wang, Xiayun, et al.
Publicado: (2023)

Neoadjuvant chemotherapy improves overall survival in resectable colorectal liver metastases patients with high clinical risk scores—— A retrospective, propensity score matching analysis
por: Chen, Feng-Lin, et al.
Publicado: (2022)

Benign gallbladder disease is a risk factor for colorectal cancer, but cholecystectomy is not: A propensity score matching analysis
por: Qin, Qiong, et al.
Publicado: (2022)

Population-level and individual-level explainers for propensity score matching in observational studies
por: Ghosh, Debashis, et al.
Publicado: (2022)

Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis
por: Li, Qing, et al.
Publicado: (2022)

1688P Outcome of older cancer patients infected with COVID-19 at Gustave Roussy Cancer Center
por: Hauchecorne, M., et al.
Publicado: (2020)

Myasthenia Gravis Is Not an Independent Prognostic Factor of Thymoma: Results of a Propensity Score Matching Trial of 470 Patients
por: Zhai, Yirui, et al.
Publicado: (2020)

The Value of Laparoscopic Simultaneous Colorectal and Hepatic Resection for Synchronous Colorectal Cancer Liver Metastasis: A Propensity Score Matching Study
por: Zhou, Jiamin, et al.
Publicado: (2022)

Prognostic significance of the Naples prognostic score in colorectal cancer patients undergoing curative resection: a propensity score matching analysis
por: Sugimoto, Atsushi, et al.
Publicado: (2023)

Transarterial Chemoembolization Combined With Apatinib for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kan, Xuefeng, et al.
Publicado: (2020)

Effects of surgery on survival of elderly patients with gallbladder cancer: A propensity score matching analysis of the SEER database
por: Xu, Xiaoming, et al.
Publicado: (2023)

The Effect of Complications on Oncological Outcomes of Colorectal Cancer Patients After Primary Surgery: A Propensity Score Matching Analysis
por: Liu, Xiao-Yu, et al.
Publicado: (2022)

Novel surgical procedure for preventing anastomotic leakage following colorectal cancer surgery: A propensity score matching study
por: Tang, Gang, et al.
Publicado: (2022)

Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis
por: Yu, Edward, et al.
Publicado: (2015)

Prognostic Analysis of Gastric Signet Ring Cell Carcinoma and Hepatoid Adenocarcinoma of the Stomach: A Propensity Score-Matched Study
por: Yang, Yu, et al.
Publicado: (2021)

Comparison of Sutureless and Conventional Laparoscopic Partial Nephrectomy: A Propensity Score-Matching Analysis
por: Zhang, Feng, et al.
Publicado: (2021)

Propensity Score Matching Analysis of the Effect of Payer Status on the Survival of Colon Cancer Patients
por: Shi, Lawrence, et al.
Publicado: (2021)

Surgical Options for Resectable Lung Adenosquamous Carcinoma: A Propensity Score-Matched Analysis
por: Zhu, Shuncang, et al.
Publicado: (2022)

Impact of missing individual patient data on 18 meta-analyses of randomised trials in oncology: Gustave Roussy experience
por: Fayard, Florence, et al.
Publicado: (2018)

Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic
por: Patrikidou, Anna, et al.
Publicado: (2018)

Head to head comparison of the propensity score and the high-dimensional propensity score matching methods
por: Guertin, Jason R., et al.
Publicado: (2016)

Prognostic relevance of rib invasion and modification of T description for resected NSCLC patients: A propensity score matching analysis of the SEER database
por: Chen, Yiyong, et al.
Publicado: (2023)

Impact of Prognostic Nutritional Index on Postoperative Pulmonary Complications in Radical Cystectomy: A Propensity Score-Matched Analysis
por: Yu, Jihion, et al.
Publicado: (2020)

Comparison of laparoscopic and open pancreaticoduodenectomy for the treatment of distal cholangiocarcinoma: A propensity score matching analysis
por: Zhu, Yuwen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ltufmltjerdl3nklspa5bv6rco